NASDAQ:KMPH - KemPharm News Headlines

$0.87
-0.01 (-1.14 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
$0.86
Now: $0.87
$0.90
50-Day Range
$0.73
MA: $1.04
$1.39
52-Week Range
$0.71
Now: $0.87
$5.43
Volume140,900 shs
Average Volume179,251 shs
Market Capitalization$25.89 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47

Headlines

KemPharm (NASDAQ KMPH) News Headlines

Source:
DateHeadline
KemPharm Inc Expected to Earn Q3 2019 Earnings of ($0.09) Per Share (NASDAQ:KMPH)KemPharm Inc Expected to Earn Q3 2019 Earnings of ($0.09) Per Share (NASDAQ:KMPH)
www.americanbankingnews.com - September 11 at 11:29 AM
KemPharm Finally Licences ADHD Drug - What Investors Should Consider - Seeking AlphaKemPharm Finally Licences ADHD Drug - What Investors Should Consider - Seeking Alpha
seekingalpha.com - September 6 at 2:52 PM
KemPharm to Present at the 21st Annual Global Investment Conference, Sponsored By HC Wainwright & Co. - NasdaqKemPharm to Present at the 21st Annual Global Investment Conference, Sponsored By HC Wainwright & Co. - Nasdaq
www.nasdaq.com - September 5 at 5:13 PM
KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital - GlobeNewswireKemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital - GlobeNewswire
www.globenewswire.com - September 5 at 5:13 PM
Local pharmaceutical firm enters partnership valued up to $493MLocal pharmaceutical firm enters partnership valued up to $493M
finance.yahoo.com - September 5 at 5:13 PM
KemPharm Inc (NASDAQ:KMPH) Given Consensus Rating of "Buy" by BrokeragesKemPharm Inc (NASDAQ:KMPH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - September 5 at 9:01 AM
Roth Capital Downgrades KemPharm (NASDAQ:KMPH) to NeutralRoth Capital Downgrades KemPharm (NASDAQ:KMPH) to Neutral
www.americanbankingnews.com - September 5 at 7:39 AM
KemPharm (NASDAQ:KMPH) Given "Buy" Rating at HC WainwrightKemPharm (NASDAQ:KMPH) Given "Buy" Rating at HC Wainwright
www.americanbankingnews.com - September 5 at 7:39 AM
KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital - Yahoo FinanceKemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital - Yahoo Finance
finance.yahoo.com - September 4 at 9:51 AM
KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point CapitalKemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital
finance.yahoo.com - September 4 at 9:51 AM
KemPharm (NASDAQ:KMPH) vs. Spero Therapeutics (NASDAQ:SPRO) Financial ContrastKemPharm (NASDAQ:KMPH) vs. Spero Therapeutics (NASDAQ:SPRO) Financial Contrast
www.americanbankingnews.com - September 3 at 2:31 PM
 Brokerages Expect KemPharm Inc (NASDAQ:KMPH) Will Announce Earnings of -$0.22 Per Share Brokerages Expect KemPharm Inc (NASDAQ:KMPH) Will Announce Earnings of -$0.22 Per Share
www.americanbankingnews.com - September 3 at 10:25 AM
KemPharm Reports Second Quarter 2019 Results Nasdaq:KMPH - GlobeNewswireKemPharm Reports Second Quarter 2019 Results Nasdaq:KMPH - GlobeNewswire
www.globenewswire.com - August 13 at 11:48 PM
KemPharm Reports Second Quarter 2019 ResultsKemPharm Reports Second Quarter 2019 Results
finance.yahoo.com - August 13 at 11:48 PM
Implied Volatility Surging for KemPharm (KMPH) Stock OptionsImplied Volatility Surging for KemPharm (KMPH) Stock Options
finance.yahoo.com - August 7 at 11:09 PM
Could The KemPharm, Inc. (NASDAQ:KMPH) Ownership Structure Tell Us Something Useful?Could The KemPharm, Inc. (NASDAQ:KMPH) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - July 5 at 6:20 PM
Top Analyst Upgrades and Downgrades: Adobe, Energizer, Marvell, MongoDB, Royal Gold, Six Flags, State Street, SunPower, TripAdvisor and More - 24/7 Wall St.Top Analyst Upgrades and Downgrades: Adobe, Energizer, Marvell, MongoDB, Royal Gold, Six Flags, State Street, SunPower, TripAdvisor and More - 24/7 Wall St.
247wallst.com - June 19 at 7:57 PM
Benzingas Top Upgrades, Downgrades For June 19, 2019 - BenzingaBenzinga's Top Upgrades, Downgrades For June 19, 2019 - Benzinga
www.benzinga.com - June 19 at 7:57 PM
Form SC 13G KEMPHARM, INC Filed by: Mangless Daniel John - StreetInsider.comForm SC 13G KEMPHARM, INC Filed by: Mangless Daniel John - StreetInsider.com
www.streetinsider.com - June 12 at 5:44 PM
KemPharm Reports First Quarter 2019 Results Nasdaq:KMPH - GlobeNewswireKemPharm Reports First Quarter 2019 Results Nasdaq:KMPH - GlobeNewswire
globenewswire.com - May 15 at 8:59 PM
KemPharm Reports First Quarter 2019 Results - NasdaqKemPharm Reports First Quarter 2019 Results - Nasdaq
www.nasdaq.com - May 14 at 8:00 PM
KemPharm Reports First Quarter 2019 ResultsKemPharm Reports First Quarter 2019 Results
finance.yahoo.com - May 14 at 8:00 PM
Analysis: Positioning to Benefit within McEwen Mining, P & F Industries, KemPharm, Viveve Medical, Genius Brands International, and Vuzix — Research Highlights Growth, Revenue, and Consolidated Results - GlobeNewswireAnalysis: Positioning to Benefit within McEwen Mining, P & F Industries, KemPharm, Viveve Medical, Genius Brands International, and Vuzix — Research Highlights Growth, Revenue, and Consolidated Results - GlobeNewswire
www.globenewswire.com - April 18 at 8:21 AM
Daily Biotech Pulse: Mercks Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug - BenzingaDaily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug - Benzinga
www.benzinga.com - April 12 at 8:19 AM
KemPharm Completes KP415 Pre-NDA Meeting with FDA - GlobeNewswireKemPharm Completes KP415 Pre-NDA Meeting with FDA - GlobeNewswire
www.globenewswire.com - April 11 at 7:44 PM
KemPharm Completes KP415 Pre-NDA Meeting with FDAKemPharm Completes KP415 Pre-NDA Meeting with FDA
finance.yahoo.com - April 11 at 7:44 PM
KemPharm: Will Optimism Win?KemPharm: Will Optimism Win?
seekingalpha.com - March 18 at 8:01 PM
KemPharm down 6% premarket on Apadaz coverage updateKemPharm down 6% premarket on Apadaz coverage update
seekingalpha.com - March 13 at 7:07 PM
KemPharm Provides Update on APADAZ® Formulary AdoptionKemPharm Provides Update on APADAZ® Formulary Adoption
finance.yahoo.com - March 13 at 8:14 AM
Loss-Making KemPharm, Inc. (NASDAQ:KMPH) Expected To BreakevenLoss-Making KemPharm, Inc. (NASDAQ:KMPH) Expected To Breakeven
finance.yahoo.com - March 7 at 7:30 PM
KemPharm to Present at Upcoming Investor Conferences - GlobeNewswireKemPharm to Present at Upcoming Investor Conferences - GlobeNewswire
globenewswire.com - March 5 at 7:01 PM
Edited Transcript of KMPH earnings conference call or presentation 28-Feb-19 9:30pm GMTEdited Transcript of KMPH earnings conference call or presentation 28-Feb-19 9:30pm GMT
finance.yahoo.com - March 2 at 6:21 PM
KemPharm (KMPH) CEO Travis Mickle on Q4 2018 Results - Earnings Call TranscriptKemPharm (KMPH) CEO Travis Mickle on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 2 at 8:17 AM
KemPharm Reports Q4 and FY 2018 Results Nasdaq:KMPH - GlobeNewswireKemPharm Reports Q4 and FY 2018 Results Nasdaq:KMPH - GlobeNewswire
globenewswire.com - February 28 at 7:04 PM
KemPharm to Report Fourth Quarter and Year End 2018 ResultsKemPharm to Report Fourth Quarter and Year End 2018 Results
finance.yahoo.com - February 21 at 6:59 PM
KemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate - GlobeNewswireKemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate - GlobeNewswire
globenewswire.com - January 31 at 6:32 PM
KemPharm Announces Enhancements to U.S. and Global Intellectual Property EstateKemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate
finance.yahoo.com - January 29 at 8:14 AM
What You Must Know About KemPharm, Inc.’s (NASDAQ:KMPH) Beta ValueWhat You Must Know About KemPharm, Inc.’s (NASDAQ:KMPH) Beta Value
finance.yahoo.com - January 21 at 6:00 PM
KemPharm Presenting Four Scientific Posters at APSARDs 2019 Annual MeetingKemPharm Presenting Four Scientific Posters at APSARD's 2019 Annual Meeting
finance.yahoo.com - January 18 at 8:36 AM
KemPharm up 15% premarket on FDA nod for new Apadaz dosesKemPharm up 15% premarket on FDA nod for new Apadaz doses
seekingalpha.com - January 7 at 6:22 PM
KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ® (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ® (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)
finance.yahoo.com - January 7 at 8:15 AM
KemPharm Delay In Partnership May Have Silver LiningKemPharm Delay In Partnership May Have Silver Lining
seekingalpha.com - December 26 at 5:31 PM
KemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug PortfolioKemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug Portfolio
finance.yahoo.com - December 19 at 8:21 AM
KemPharm Presents Poster at ACNP’s 57th Annual Meeting Highlighting the Intravenous Abuse Potential of Serdexmethylphenidate (SDX)KemPharm Presents Poster at ACNP’s 57th Annual Meeting Highlighting the Intravenous Abuse Potential of Serdexmethylphenidate (SDX)
finance.yahoo.com - December 12 at 8:20 AM
KemPharm Webcast on VirtualInvestorConferences.com Now Available for On-Demand ViewingKemPharm Webcast on VirtualInvestorConferences.com Now Available for On-Demand Viewing
finance.yahoo.com - December 11 at 8:46 AM
Form 8-K KEMPHARM, INC For: Dec 06 - StreetInsider.comForm 8-K KEMPHARM, INC For: Dec 06 - StreetInsider.com
www.streetinsider.com - December 7 at 5:41 PM
KemPharm to Webcast Live at VirtualInvestorConferences.com on December 6thKemPharm to Webcast Live at VirtualInvestorConferences.com on December 6th
finance.yahoo.com - December 3 at 8:19 AM
What Kind Of Shareholders Own KemPharm Inc (NASDAQ:KMPH)?What Kind Of Shareholders Own KemPharm Inc (NASDAQ:KMPH)?
finance.yahoo.com - November 26 at 5:18 PM
Form SC 13G/A KEMPHARM, INC Filed by: Flynn James EForm SC 13G/A KEMPHARM, INC Filed by: Flynn James E
www.streetinsider.com - November 23 at 8:27 AM
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use DisorderKemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use Disorder
finance.yahoo.com - November 13 at 8:16 AM
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel